Asian stocks set to rise as drug trials, data push Wall Street higher

By Katanga Johnson WASHINGTON (Reuters) - Asian stocks were set to climb on Wednesday after another late Wall Street surge in response to upbeat trial results for a COVID-19 treatment and data showing U.S. consumers spent big in May. The prospects of fresh support from the Federal Reserve and Bank of Japan also supported global equity markets.

The post Asian stocks set to rise as drug trials, data push Wall Street higher appeared first on Firstpost.

from Firstpost